Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study
Authors:
- 1 January 2016
- journal article
- clinical trial
- Published by Edikta s.r.l. in Functional Neurology
- Vol. 31 (1) , 33-37
Abstract
There is growing evidence that headaches are connected to melatonin secretion. Our aim was to assess the potential effectiveness of melatonin for primary headache prevention.Keywords
This publication has 22 references indexed in Scilit:
- Severity classification on the Hamilton depression rating scaleJournal of Affective Disorders, 2013
- Melatonin, 3 mg, is effective for migraine preventionNeurology, 2004
- Effects of intrathecal injections of melatonin analogs on capsaicin-induced secondary mechanical allodynia and hyperalgesia in ratsPain, 2004
- Melatonin-induced inhibition of spinal cord synaptic potentiation in rats is MT2 receptor-dependentNeuroscience Letters, 2004
- A six-item short-form survey for measuring headache impact: The HIT-6™Quality of Life Research, 2003
- Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofolBritish Journal of Anaesthesia, 2003
- Role of Melatonin in the Regulation of Human Circadian Rhythms and SleepJournal of Neuroendocrinology, 2003
- Effects of melatonin, morphine and diazepam on formalin-induced nociception in miceLife Sciences, 2001
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSLEEP, 1991
- Nocturnal Plasma Melatonin Levels in Migraine: A Preliminary ReportHeadache: The Journal of Head and Face Pain, 1989